
==== Front
Cureus
Cureus
2168-8184
Cureus
2168-8184
Cureus Palo Alto (CA)

10.7759/cureus.67030
Gastroenterology
Pathology
General Surgery
Intra-ampullary and Periampullary Carcinoma: Clinicopathological Comparison and Survival Outcomes
Muacevic Alexander
Adler John R
Hashmi Atif A 1
Ali Ramla 2
Jamal Syed Sualeh 3
Zafar Sumbal 1
Zia Shamail 4
Zia Fazail 4
Anjali FNU 5
Kirshan Kumar Sanjay 6
Irfan Muhammad 7
1 Pathology, Liaquat National Hospital and Medical College, Karachi, PAK
2 Internal Medicine, Liaquat National Hospital and Medical College, Karachi, PAK
3 Internal Medicine, Baqai Medical University, Karachi, PAK
4 Pathology, Jinnah Sindh Medical University, Karachi, PAK
5 Internal Medicine, Sakhi Baba General Hospital, Sukkur, PAK
6 Internal Medicine, Bahria University Medical and Dental College, Karachi, PAK
7 Statistics, Liaquat National Hospital and Medical College, Karachi, PAK
Atif A. Hashmi atifhashmi345@gmail.com
16 8 2024
8 2024
16 8 e6703015 8 2024
Copyright © 2024, Hashmi et al.
2024
Hashmi et al.
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article is available from https://www.cureus.com/articles/282455-intra-ampullary-and-periampullary-carcinoma-clinicopathological-comparison-and-survival-outcomes
Introduction

The ampulla of Vater is a structure in the duodenal wall in which the biliary and pancreatic ducts open. Malignant epithelial tumors arising at this site are commonly referred to as ampullary adenocarcinomas. In this study, we compared the clinicopathological features of intra-ampullary and periampullary carcinomas, including survival outcomes.

Methods

This retrospective cross-sectional study was conducted at the Department of Pathology, Liaquat National Hospital. All radiologically suspected cases or biopsy-proven (endoscopic biopsy) cases of intra-ampullary/periampullary carcinoma were included in the study. All patients underwent surgical resection (Whipple’s procedure/pancreatoduodenectomy). The classification of intra-ampullary and periampullary carcinomas was performed according to the College of American Pathologists (CAP) guidelines.

Results

Among the 188 case studies, most (61.7%, n = 116) were males, with a median age of 55 years. Most tumors were of the pancreatobiliary subtype (57.4%, n = 108). Similarly, intra-ampullary carcinoma was more common than periampullary carcinoma (61.7% vs. 38.3%). Intra-ampullary carcinoma showed a higher extent of involvement of adjacent structures, a higher frequency of perineural invasion, and a higher nodal stage than periampullary carcinoma. Similarly, the median disease-specific survival of intra-ampullary carcinoma was significantly lower (46 months) than that of periampullary carcinoma (53.5 months).

Conclusion

We found a higher incidence of intra-ampullary carcinoma in our study. In addition, intra-ampullary carcinoma had a worse survival rate and was associated with poorer pathological parameters, such as perineural invasion and higher nodal and tumor stages than periampullary carcinoma.

pancreatic carcinoma
intestinal
pancreatobiliary
periampullary carcinoma
intra-ampullary carcinoma
ampullary carcinoma
==== Body
pmcIntroduction

The ampulla of Vater refers to the structure in the duodenal wall in which the biliary and pancreatic ducts open. It is lined by pancreatobiliary-type mucosa, and outside surfaces are lined by enteric-type mucosa. Malignant epithelial tumors arising at this site are commonly referred to as ampullary adenocarcinomas. These tumors are a heterogeneous group because of the complex nature of the ampulla [1]. Owing to clinical and histopathological differences, they are divided into intra-ampullary and periampullary carcinomas. Intra-ampullary carcinomas arise within the ampulla and are more likely to cause obstructive jaundice. Periampullary carcinoma arises from the duodenal surface of the papillae, and it is detected late. Because of the complex anatomy of the ampulla, it is often difficult to characterize these tumors. Moreover, it is important to differentiate these tumors from pancreatic ductal adenocarcinomas and bile duct cancers. Therefore, a careful gross examination is mandatory for definite categorization.

Various pathological parameters determine the prognosis of ampullary cancer. These include nodal metastasis, the extent of tumor involvement of adjacent structures, perineural invasion (PNI), and lymphovascular invasion (LVI) [2,3]. Moreover, there are two common histological types of ampullary carcinoma, pancreatobiliary and intestinal, with notable prognostic differences [4]. Studies have also shown differences in survival between intra-ampullary and periampullary carcinomas [1]. However, reports from different parts of the world regarding differences in survival among these tumor types are contradictory, and various parameters other than intrinsic tumor features, such as obstructive jaundice and stage of presentation, can affect survival. Therefore, devising treatment/management guidelines based on locoregional data are imperative. Therefore, in this study, we compared the clinicopathological features of intra-ampullary and periampullary carcinomas, including survival outcomes.

Materials and methods

Study design, setting, and inclusion criteria

This retrospective cross-sectional study was conducted at the Department of Pathology, Liaquat National Hospital. All radiologically suspected or biopsy-proven (endoscopic biopsy) cases of ampullary/periampullary adenocarcinoma were included in the study. All patients underwent surgical resection (Whipple’s procedure/pancreatoduodenectomy). Surgical resections were performed at the Liaquat National Hospital from January 2019 to December 2023. Patients with incomplete surgical records, lack of clinical follow-up, or unavailability of histopathological data were excluded from the study. In addition, patients with tumors located in the head of the pancreas, bile ducts, or gallbladder, in addition to those receiving prior neoadjuvant chemotherapy or radiation, were excluded. The categorization of intra-ampullary and periampullary carcinomas was performed according to the College of American Pathologists (CAP) guidelines. Intra-ampullary carcinomas included those arising from the ampullary duct. In contrast, periampullary carcinomas included ampullary duodenal tumors arising from the duodenal surface of the papillae. Mixed ampullary and periampullary carcinomas were excluded from the study. Histological categorization into pancreatobiliary and intestinal subtypes was performed using routine hematoxylin and eosin staining with adjunctive caudal-type homeobox transcription factor 2 (CDX2) staining in all cases and cytokeratin 7 (CK7), cytokeratin 20 (CK20), and mucin (MUC) staining in a limited number of cases. Histological evaluation was performed by two senior histopathologists.

Pathological data and clinical follow-up

After surgical resection, pancreatoduodenectomy specimens were sent to the histopathology laboratory. A gross pathological examination was performed after formalin fixation. The dimensions of the stomach, duodenum, and pancreas were also noted. Surgical margins were inked, and representative pancreatic neck, retroperitoneal/uncinate (corresponding to superior mesenteric artery surface), common bile duct/common hepatic duct, and proximal (stomach) and distal (duodenal) margins were submitted. Moreover, the surfaces, including the vascular groove (corresponding to the superior mesenteric vein) and anterior pancreatic surface, were also inked with different colors. After securing the margins, the duodenum and stomach were opened along the greater curvature, and the ampullary area was thoroughly examined for any irregularity, mass, nodule, or color change. The pancreas was then opened along the common bile duct and pancreatic duct simultaneously up to the ampulla, and the exact location of the tumor (intra-ampullary vs. periampullary) was established. The tumor is submitted in entirety in relation to adjacent structures, along with representative sections of the stomach, duodenum, pancreas, bile duct, gall bladder (if present), and peri-pancreatic and peri-duodenal fat for the lymph nodes. Tumor size, location, and extent of involvement were noted. Histopathological findings were examined by experienced pathologists, and the final tumor classification, grade, and staging were performed. Clinical data on disease recurrence and survival were obtained from clinical records.

Statistical analysis

The data were analyzed using the IBM SPSS Statistics for Windows, Version 26 (Released 2019; IBM Corp., Armonk, New York, United States). The mean and standard deviation, median, and interquartile range of quantitative variables were calculated. Frequencies and percentages for qualitative variables were calculated. Chi-square and Fisher's exact tests were applied to determine the association between clinicopathological parameters and tumor subtypes. Kaplan-Meir survival curves were used for survival analysis.

Results

Clinicopathological features of ampullary carcinomas

Of the 188 case studies, most (61.7%, n = 116) were male, with a median age of 55 years. Most tumors were well differentiated (53.2%, n = 100), with peripancreatic tissue involvement observed in 40.4% (n = 76) of cases. LVI, PNI, and nodal metastasis were observed in 27.7% (n = 52), 42.6% (n = 80), and 42.6% (n = 80) of cases, respectively. Most tumors were of the pancreatobiliary subtype (57.4%, n = 108). Similarly, intra-ampullary carcinoma was more common than periampullary carcinoma (61.7% vs. 38.3%), as shown in Table 1.

Table 1 Descriptive statistics of study population

IQR:  Inter-quartile range; N: nodal. Data has been presented as median (IQR) and n (%)

Clinicopathological parameters	Values	
Gender	 	
Female, n (%)	72 (38.3)	
Male, n (%)	116 (61.7)	
Age (years)	 	
Median (IQR)	55 (44-60)	
Age groups	 	
≤50 years, n (%)	60 (31.9)	
>50 years, n (%)	128 (68.1)	
Tumor size (cm)	 	
Median (IQR)	2.70 (2.00-3.80)	
Tumor size groups	 	
<2 cm, n (%)	32 (17)	
2-5 cm, n (%)	140 (74.5)	
>5 cm, n (%)	16 (8.5)	
Follow up duration (months)	 	
Median (IQR)	44.00 (38.00-55.00)	
Tumor grade	 	
Grade 1/well-differentiated, n (%)	100 (53.2)	
Grade 2/moderately differentiated, n (%)	72 (38.3)	
Grade 3/poorly differentiated, n (%)	16 (8.5)	
Tumor extent	 	
Limited ampulla, n (%)	8 (4.3)	
Invades muscularis propria, n (%)	72 (38.3)	
Invades pancreas up to 0.5 cm, n (%)	4 (2.1)	
Invades into peripancreatic soft tissues, n (%)	76 (40.4)	
Invades into peri duodenal tissues, n (%)	28 (14.9)	
Lymphovascular invasion	 	
Present, n (%)	52 (27.7)	
Absent, n (%)	136 (72.3)	
Perineural invasion	 	
Present, n (%)	80 (42.6)	
Absent, n (%)	108 (57.4)	
Nodal metastasis	 	
Present, n (%)	80 (42.6)	
Absent, n (%)	108 (57.4)	
Nodal (N) stage	 	
N0, n (%)	80 (42.6)	
N1, n (%)	84 (44.7)	
N2, n (%)	24 (12.8)	
Tumor type	 	
Intestinal, n (%)	72 (38.3)	
Pancreatobilliary, n (%)	108 (57.4)	
Neuroendocrine differentiation, n (%)	8 (4.3)	
Tumor site	 	
Intra-ampullary, n (%)	116 (61.7)	
Periampullary, n (%)	72 (38.3)	

Comparison of clinicopathological features of intra-ampullary and periampullary carcinoma

Table 2 compares the clinicopathological features of the two groups of ampullary carcinomas (intra-ampullary and periampullary). A significant association was noted with respect to tumor extent, PNI, and nodal metastasis. Intra-ampullary carcinoma showed a higher extent of involvement of adjacent structures, higher frequency of PNI, and higher nodal stage than periampullary carcinoma.

Table 2 Association of intra-ampullary and periampullary carcinoma with clinicopathological parameters

N: nodal. Data has been presented as n (%). Chi-square/Fisher's exact test was applied. *p-value significant as <0.05

Clinicopathological parameters  	Values	p-value	
Intra-ampullary	Periampullary	
Gender	 	 	 	
Female, n (%)	48 (41.4)	24 (33.3)	0.270	
Male, n (%)	68 (58.6)	48 (66.7)	
Age groups	 	 	 	
≤50 years, n (%)	36 (31)	24 (33.3)	0.742	
>50 years, n (%)	80 (69)	48 (66.7)	
Tumor size	 	 	 	
<2 cm, n (%)	24 (20.7)	8 (11.1)	0.174	
2-5 cm, n (%)	84(72.4)	56 (77.8)	
>5 cm, n (%)	8 (6.9)	8 (11.1)	
Tumor grade	 	 	 	
Grade 1/well-differentiated, n (%)	60 (51.7)	40 (55.6)	0.514	
Grade 2/moderately differentiated, n (%)	44 (37.9)	28 (38.9)	
Grade 3/poorly differentiated, n (%)	12 (10.3)	4 (5.6)	
Tumor extent	 	 	 	
Limited ampulla, n (%)	4 (3.4)	4 (5.6)	0.045*	
Invades muscularis propria, n (%)	36 (31)	36 (50)	
Invades pancreas up to 0.5 cm, n (%)	4 (3.4)	0 (0)	
Invades into peripancreatic soft tissues, n (%)	52 (44.8)	24 (33.3)	
Invades into periduodenal tissues, n (%)	20 (17.2)	8 (11.1)	
Lymphovascular invasion	 	 	 	
Present, n (%)	28 (24.1)	24 (33.3)	0.171	
Absent, n (%)	88 (75.9)	48 (66.7)	
Perineural invasion	 	 	 	
Present, n (%)	56 (48.3)	24 (33.3)	0.044*	
Absent, n (%)	60 (51.7)	48 (66.7)	
Nodal metastasis	 	 	 	
Present, n (%)	68 (58.6)	40 (55.6)	0.679	
Absent, n (%)	48 (41.4)	32 (44.4)	
Nodal (N) stage	 	 	 	
N0, n (%)	48 (41.4)	32 (44.4)	0.003*	
N1, n (%)	60 (51.7)	24 (33.3)	
N2, n (%)	8 (6.9)	16 (22.2)	
Tumor type	 	 	 	
Intestinal, n (%)	48 (41.4)	24 (33.3)	0.464	
Pancreatobilliary, n (%)	64 (55.2)	44 (61.1)	
Neuroendocrine differentiation, n (%)	4 (3.4)	4 (5.6)	

Survival (disease-specific survival) analysis of intra-ampullary and periampullary carcinoma

Table 3 shows that the median disease-specific survival of intra-ampullary carcinoma was significantly lower (46 months) than that of periampullary carcinoma (53.5 months).

Table 3 Means and medians for disease-specific survival (Intra-ampullary and periampullary carcinoma)

CI: confidence interval. Data has been presented as mean (standard deviation) and median (inter-quartile range). p-value significant as <0.05

Tumor type	Number of events	Mean (95% CI)	Median (95% CI)	Log rank p-value	
Intra-ampullary (n = 116)	72	46.08 (44.075-48.085)	46.000 (43.369-48.631)	<0.001*	
Periampullary (n = 72)	32	53.538 (51.323-55.754)	57.000 (54.789-59.211)	
Overall (n = 188)	104	48.818 (47.236-50.40)	53.000 (48.89-57.11)	

Figure 1 depicts the comparison of survival analysis of these two groups of tumors (intra-ampullary and periampullary) using Kaplan-Meier curves. Disease-specific survival was better in patients with periampullary carcinoma than in those with intra-ampullary cancer (p < 0.001). 

Figure 1 Kaplan-Meier curve for disease-specific survival (intra-ampullary and periampullary carcinoma)

Discussion

In this study, we evaluated the clinicopathological features and survival analysis of intra-ampullary and peri-ampullary carcinomas and found that intra-ampullary carcinomas were significantly associated with poor pathological parameters, such as PNI and higher disease stage. Similarly, intra-ampullary carcinoma showed lower disease-specific survival than peri-ampullary carcinoma.

Adsay et al. [1] recommended four distinct subtypes of ampullary adenocarcinoma: invasive carcinoma arising from intra-ampullary papillary-tubular neoplasm (IAPN), ampullary ductal adenocarcinoma, and peri-ampullary duodenal and ampullary carcinoma not otherwise specified. Among these tumors, the first two categories were collectively labeled intra-ampullary carcinoma, as per the CAP protocol. Adsay et al. reported different pathological features and outcomes of ampullary carcinoma arising from IAPN and ampullary ductal. They reported the worst outcomes of ampullary ductal carcinoma, with a three-year survival rate of 41%. Because most intra-ampullary carcinomas are ampullary ductal, these findings correlate with our study findings, emphasizing the worst outcome of intra-ampullary carcinomas. Contrary to these findings, a few authors have questioned the distinction between ampullary carcinomas and other pancreatobiliary carcinomas of the same histology. Westgaard et al. [5] conducted a study involving 207 pancreatoduodenectomy specimens and revealed that ampullary carcinomas have the same long-term outcomes as pancreatic, duodenal, and biliary carcinomas of the same histological type. Therefore, the authors emphasized the importance of pancreatobiliary and intestinal differentiation. They found that 63% of their patients had pancreatobiliary differentiation. We also found the pancreatobiliary subtype to be the most common histological type (57.4%).

There are two main histological subtypes of ampullary carcinomas: pancreatobiliary and intestinal. Previous studies have reported poorer outcomes in patients with pancreatobiliary than intestinal carcinoma [6,7]. Our results showed that 55.2% of intra-ampullary carcinomas had a pancreatobiliary histological subtype, indicating the importance of histological typing in ampullary carcinoma.

Multiple studies have emphasized that ampullary carcinomas have better outcomes than pancreatic ductal adenocarcinomas [8-10]. The primary reason was a relatively early presentation of ampullary carcinoma associated with biliary obstruction. Conversely, pancreatic cancers grow insidiously and present late in the disease course. We did not compare outcomes between pancreatic cancer and ampullary carcinoma.

Despite different clinical outcomes and distinct nomenclature, it remains controversial whether intra-ampullary and peri-ampullary carcinomas are biologically and genetically distinct. Tumor protein 53 (TP53), Kirsten rat sarcoma virus protein (KRAS), breast cancer type 1 and 2 susceptibility proteins (BRCA1/2), mothers against decapentaplegic homolog 4 (SMAD4), and microsatellite instability-related molecular alterations are described in ampullary carcinomas, and these also seem to correlate with histological subtypes, i.e., pancreatobiliary and intestinal [11]. In our study, we did not evaluate the molecular features of ampullary carcinoma.

Limitations

A major limitation of our study was the lack of molecular evaluation of intra-ampullary and peri-ampullary carcinomas. It is important to compare the molecular features of these two groups of tumors to understand whether the difference in survival is based only on tumor location or genetic characteristics. Second, given that this was a single-center study conducted at a private hospital, the results cannot be extrapolated to the entire population; therefore, multicenter studies are needed, especially those involving public sector hospitals, to specifically understand the survival difference between these two groups of tumors.

Conclusions

In this study, we found that intra-ampullary carcinomas comprise most ampullary carcinomas. In addition, intra-ampullary carcinomas showed poorer disease-specific survival than peri-ampullary carcinomas. Moreover, intra-ampullary carcinomas are associated with worse prognostic parameters, such as extent of involvement, nodal metastasis, and PNI.

Disclosures

Author Contributions

Human subjects: Consent was obtained or waived by all participants in this study. NA issued approval NA. IRB was not needed as it was a retrospective study (as per institutional policy).

Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue.

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following:

Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.

Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.

Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Concept and design:  Atif A. Hashmi, Ramla Ali, Syed Sualeh Jamal, FNU Anjali, Sanjay Kirshan Kumar

Acquisition, analysis, or interpretation of data:  Atif A. Hashmi, Ramla Ali, Syed Sualeh Jamal, Sumbal Zafar, Shamail Zia, Fazail Zia, Muhammad Irfan

Drafting of the manuscript:  Atif A. Hashmi, Ramla Ali, Syed Sualeh Jamal, Sumbal Zafar, Shamail Zia, Fazail Zia, Muhammad Irfan, FNU Anjali, Sanjay Kirshan Kumar

Critical review of the manuscript for important intellectual content:  Atif A. Hashmi, Shamail Zia, Fazail Zia

Supervision:  Atif A. Hashmi
==== Refs
References

1 Ampullary region carcinomas: definition and site specific classification with delineation of four clinicopathologically and prognostically distinct subsets in an analysis of 249 cases Am J Surg Pathol Adsay V Ohike N Tajiri T 1592 1608 36 2012 23026934
2 Prognostic nomogram for disease-specific survival in patients with non-metastatic ampullary carcinoma after surgery Ann Surg Oncol Li HB Zhao FQ Zhou J 1079 1085 26 2019 30659390
3 Perineural invasion is a strong prognostic moderator in ampulla of Vater carcinoma: a meta-analysis Pancreas Luchini C Veronese N Nottegar A 70 76 48 2019 30451797
4 Role of immunohistochemistry in the subtyping of periampullary adenocarcinoma Int J Surg Pathol Bakshi N Dhawan S Nundy S Rao S Chopra P Bhalla S 598 608 27 2019 30942099
5 Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies? Ann Surg Oncol Westgaard A Pomianowska E Clausen OP Gladhaug IP 430 439 20 2013 22956064
6 Histomorphologic and molecular phenotypes predict gemcitabine response and overall survival in adenocarcinoma of the ampulla of Vater Surgery Schiergens TS Reu S Neumann J 151 161 158 2015 25819575
7 The clinicopathologic and immunohistochemical characteristics of ampulla of Vater carcinoma: the intestinal type is associated with a better prognosis Hepatogastroenterology Roh YH Kim YH Lee HW Kim SJ Roh MS Jeong JS Jung GJ 1641 1644 54 2007 https://pubmed.ncbi.nlm.nih.gov/18019683/ 18019683
8 Distribution and pathological features of pancreatic, ampullary, biliary and duodenal cancers resected with pancreaticoduodenectomy World J Surg Oncol Chandrasegaram MD Chiam SC Chen JW 85 13 2015 25890023
9 Prognostic relevance of number and ratio of metastatic lymph nodes in resected pancreatic, ampullary, and distal bile duct carcinomas Ann Surg Oncol Pomianowska E Westgaard A Mathisen Ø Clausen OP Gladhaug IP 233 241 20 2013 22893118
10 Prognostic significance of tumour location after adjuvant chemoradiotherapy for periampullary adenocarcinoma Clin Transl Oncol Kim K Chie EK Jang JY 391 395 14 2012 22551547
11 Ampulla of Vater carcinoma: advancement in the relationships between histological subtypes, molecular features, and clinical outcomes Front Oncol Liang H Zhu Y Wu YK 1135324 13 2023 37274233
